Literature DB >> 31807058

Transcriptome Changes In Dorsal Spinal Cord Of Rats With Neuropathic Pain.

Song Cao1,2, Jie Yuan1,2, Dexing Zhang1, Song Wen1, Jie Wang1, Ying Li1, Wenwen Deng3.   

Abstract

BACKGROUND: Mechanisms of neuropathic pain are not fully understood. Molecular changes in spinal dorsal horn take part in the initiation and development of neuropathic pain.
METHODS: To detect the transcriptome changes in the dorsal spinal cord of neuropathic pain rat, sciatic nerve chronic constriction injury (CCI) rats were used. Then, the CCI ipsilateral dorsal spinal cords of lumbar L3-L5 segments were collected at 14th day post-CCI and subjected to microRNA and long non-coding RNA (lncRNA)/mRNA microarray. To evaluate functions of differential mRNAs, bioinformatics methods including gene ontology (GO) and KEGG pathway analysis were conducted for significantly up- and downregulated mRNAs.
RESULTS: MicroRNA microarrays showed that 13 microRNAs were differently expressed between CCI and sham-operated rats (fold change ≥ 2.0). Six of them were upregulated, and the other seven were downregulated in CCI group. MicroRNA-1b overexpressed 18.7 times after CCI. LncRNA/mRNA microarray detected 876 lncRNAs with significant differential expression (fold change ≥ 2.0). Among them, 339 were significantly upregulated, and 537 were downregulated in CCI group. Sixteen of them differentially expressed more than 10 times and the lncRNA XR_356687 overexpressed as high as 53 times. In addition, 950 mRNAs were differentially expressed (fold change ≥ 2.0), including 405 upregulated and 545 downregulated in CCI group. Ten of these mRNAs with changed expressions of more than 10 times. The Hspa1b (encodes heat shock protein 70) overexpressed 24 times in CCI rats. Gene ontology analysis revealed that hundreds of differentially expressed mRNAs involved in the biological processes, cellular component, and molecular function. In addition, these genes significantly enriched into 32 KEGG pathways, including the TNF, FoxO, cytokine-cytokine receptor interaction, and calcium signaling pathways.
CONCLUSION: Neuropathic pain induced comprehensive changes of transcription profile in the dorsal spinal cord. These differentially expressed transcripts in spinal cord could be potential targets in defeating neuropathic pain.
© 2019 Cao et al.

Entities:  

Keywords:  chronic constriction injury; long non-coding RNA; mRNA; microRNA; neuropathic pain; pathways; peripheral nerve injury; spinal dorsal horn

Year:  2019        PMID: 31807058      PMCID: PMC6850707          DOI: 10.2147/JPR.S219084

Source DB:  PubMed          Journal:  J Pain Res        ISSN: 1178-7090            Impact factor:   3.133


Introduction

Neuropathic pain is still a major health and economic burden worldwide.1,2 However, the mechanisms of neuropathic pain are not fully understood, and the elucidation of molecular changes during neuropathic pain is fundamental for the development of mechanism-oriented treatments.3 Spinal dorsal horn is the docking site of primary and secondary sensory neurons. It also harbors the descending terminals from supraspinal structures, such as locus coeruleus and periaqueductal grey.4–6 Evidence shows that spinal dorsal horn plays important roles in the generation and maintain of neuropathic pain, because it is one of the key areas where central sensitization take place in neuropathic pain and other kinds of chronic pain situation.7–10 Therefore, transcriptomic changes of functional molecules such as mRNAs and non-coding RNAs in the spinal dorsal horn influence the development and outcome of pathological pain.11,12 MicroRNAs are small non-coding molecules, which post-transcriptionally modulate many kinds of pathological processes including neuropathic pain.13,14 Abnormal expression of microRNA in spinal cord has been reported in animal models of neuropathic pain.15 More than 100 microRNAs were detected abnormally expressed in the dorsal horn of CCI rats with TaqMan® Low Density Array.16 By using sequencing analysis,17 12 differential microRNAs were detected in spinal cord of spared nerve injury (SNI) rats. It is also reported that miR-203,18 miR-155,19 and miR-38120 showed abnormal expression in the dorsal spinal cord of CCI rats. Microarray analysis of microglia derived from dorsal spinal cord showed that miR-29c may be involved in the occurrence and maintenance of neuropathic pain in L4 spinal nerve transected mice.21 Long non-coding RNAs (lncRNAs) are more than 200 nucleotides in length. Although without protein-coding potential, lncRNAs regulate gene expression and they are characterized as key modulators of neuronal functions.22 Emerging evidence showed that lncRNAs were differentially expressed and play pivotal roles in the situation of neuropathic pain.23 For example, lncRNA CRNDE upregulated in the dorsal spinal cord enhanced neuropathic pain via modulating miR-136/IL6R axis and neuroinflammation in CCI rats.24 LncRNA XIST in the spinal cord accelerated neuropathic pain progression through regulation of miR-150 and ZEB1 in CCI rat models.25 An lncRNA named as Kcna2 antisense RNA facilitates neuropathic pain by silencing Kcna2 in primary afferent neurons.26 LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia.27 LncRNA BC168687 in the dorsal root ganglion is involved in TRPV1-mediated diabetic neuropathic pain in rats.28 mRNA and lncRNA microarrays of spinal cord tissue identified a total of 511 lncRNAs and 493 mRNAs with significant differential expression in spinal nerve ligation (SNL) mice.29 By using whole transcriptome shotgun sequencing, 134 lncRNA and 1066 mRNAs were found to be significantly deregulated on day 14 post-surgery in SNI rats.17 A total of 1200 lncRNAs and 739 mRNAs were differentially expressed in the ipsilateral spinal cord of SNI mice.30 However, when neuropathic pain occurs, the expression profile and specific neuropathic pain regulation mechanisms of lncRNA in the dorsal horn of spinal cord are largely unknown. In view of the inconsistent changes of transcripts in spinal cord in neuropathic pain models, more transcriptomics studies are needed to focus on molecular changes in the dorsal spinal cord. To detect transcriptomic changes in the dorsal spinal cord during neuropathic pain and to explore the expression profiles of microRNA, lncRNA, and mRNAs, we established the widely used CCI neuropathic pain model and detected the differentially expressed transcripts with microRNA and lncRNA/mRNA microarrays. Differentially expressed mRNAs were subjected to Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses to evaluate their functions and possible mechanisms.

Methods

Animals

Experimental protocols were approved by the Experimental Animal Care and Use Committee of Zunyi Medical University. All experimental processes were carried out in accordance with the Guide for the Care and Use of Laboratory Animals.31 Sprague–Dawley rats (male, 7–8 weeks, 250 to 300 g) were housed under approved conditions with 12-/12-hr light/dark cycles with food and water provided ad libitum. Twelve rats were used in this study.

Neuropathic Pain Model

The left sciatic nerve underwent CCI surgeries to induce neuropathic pain. Animals were randomly allocated to sham operation (Sham) or CCI group (n=6 in each group). Neuropathic pain was induced with the CCI as previously described by Bennett and Xie32 with a 5–0 chromic gut suture.33 In brief, after sodium pentobarbital anesthesia (35 mg/kg, i.p.), after the sciatic nerve of the mid-thigh level on the left side was exposed, four snug ligatures of chromic gut suture were loosely tied around the nerve with about 1-mm space between the knots, so as not to compromise the vascular supply. Sham rats underwent the same anesthesia and surgical procedures but the sciatic nerves were not ligated.

Mechanical Pain Threshold Testing

Baseline mechanical pain thresholds were detected for the aforementioned 12 rats before CCI surgery. Mechanical pain intensity was monitored at 2, 6, 10, and 14 days post-surgery. Mechanical hypersensitivity was determined using the electronic von Frey plantar aesthesiometer (model 2390, IITC, Wood Dale, IL, USA) as we previously reported.34 Before tests, rats were given 15 min to settle down and habituate to the test environment. A rigid polypropylene tip was applied against the mid-plantar surface of the left hind paw. The paw withdrawal threshold was automatically recorded by the device and the cut-off was set at 50 g. The rigid tip was presented perpendicularly to the plantar surface, and brisk withdrawal or paw flinching was considered as positive responses; the digital number presented on the monitor was recorded as the paw mechanical withdrawal threshold (MWT). Three successive stimuli were applied and data were represented by mean values.

Thermal Pain Threshold Testing

Baseline thermal pain thresholds were detected for the aforementioned 12 rats before CCI surgery. To assess nociceptive responses to thermal stimuli, rats were unrestrained and acclimatized in acrylic cubicle (10 × 20 ×12 cm) on a uniform glass surface up to 60 mins before testing. Radiant heat was applied to the plantar surface of the test paw and a cut-off time of 20 s was used to prevent tissue damage. The thermal withdrawal latency from the radiant heat was recorded with a plantar test (Hargreaves’ method35) analgesia meter (model 390, IITC Life Science, Woodland Hills, CA, USA). Abrupt paw withdrawal, licking, and shaking were taken to be positive responses.36

Ipsilateral Dorsal Spinal Cord Samples Collection

Two weeks post-surgery, rats were deeply anesthetized with isoflurane and decapitated. The lumbar enlargement segments (L3-L5) of spinal cords were transversely sectioned and hemi-dissected along the midline. Only the surgery ipsilateral dorsal half of the lumbar enlargement was collected under a microscope and stored at −80°C.37

RNA Isolation, Purification, And Hybridization

Samples of Sham and CCI group were collected by pooling 6 ipsilateral L3-L5 dorsal spinal cords. Total RNA from each sample was quantified using the NanoDrop (ND-1000, NanoDrop, USA) and RNA integrity was determined by gel electrophoresis. MicroRNA labeling and array hybridization were according to Exiqon’s manual. After stopping the labeling procedure, the Hy3™-labeled samples were hybridized on the miRCURYTM LNA Array (v.19.0) (Exiqon) according to array manual. Then, the slides were scanned using the Axon GenePix 4000B microarray scanner (Axon Instruments, Foster City, CA). For lncRNA microarray, sample labeling and array hybridization were performed according to the Agilent One-Color Microarray-Based Gene Expression Analysis protocol (Agilent Technology) with minor modifications. Briefly, mRNA was purified and each sample was amplified and transcribed into fluorescent cRNA along the entire length of the transcripts without 3ʹ bias utilizing a random priming method (Arraystar Flash RNA Labeling Kit, Arraystar). The labeled cRNAs were purified by RNeasy Mini Kit (Qiagen). The concentration and specific activity of the labeled cRNAs were measured by NanoDrop and fragmented, and then the hybridization solution was dispensed into the gasket slide and assembled to the LncRNA expression microarray slide. The slides were incubated for 17 hrs at 65°C in an Agilent Hybridization Oven. The hybridized arrays were washed, fixed, and scanned using the Agilent DNA Microarray Scanner (part number G2505C).

Microarray Data Analysis

MicroRNA array images were then imported into GenePix Pro 6.0 software (Axon) for grid alignment and data extraction. MiRNAs that with intensities≥30 in all samples were chosen for calculating normalization factor. Agilent Feature Extraction software (version 11.0) was used to analyze acquired lncRNA array images. Quantile normalization and subsequent data processing were performed using the GeneSpring GX v12.1 software package (Agilent Technologies). After quantile normalization of the raw data, LncRNAs and mRNAs that have flags in Present or Marginal (“All Targets Value”) were chosen for further data analysis. Differentially expressed microRNAs, lncRNAs, and mRNAs between two samples were identified through fold change filtering. RNAs having fold changes ≥2 were set as significantly differentially expressed. Hierarchical clustering was performed to show the distinguishable expression pattern of microRNAs, lncRNAs, and mRNAs between Sham and CCI group.

Bioinformatics Analysis

Gene Ontology (GO) analyses were performed to explore the function of differential mRNAs in terms of biological processes, cellular components, and molecular functions. Pathways defined by Kyoto Encyclopedia of Genes and Genomes (KEGG), Biocarta and Reactome () were identified by Database for Annotation, Visualization and Integrated Discovery (DAVID; ).

Statistical Analysis

The results were reported as mean ± SD. Statistically significant differences of mechanical and thermal pain thresholds between Sham and CCI groups were estimated by the repeated measures two-way Analysis of Variance (ANOVA) followed by Sidak’s multiple comparisons tests with GraphPad Prism (v7.0, GraphPad Software, USA). P < 0.05 was considered as being statistically significant.

Results

Neuropathic Pain Model Confirmation With Mechanical Hypersensitivity After CCI Surgery

Compared with control rats (Sham group), rats with neuropathic pain (CCI group) showed significantly increased mechanical (Figure 1A) and thermal hypersensitivity (Figure 1B) on the ipsilateral hind paw in the next 2 weeks after CCI surgery.
Figure 1

CCI of sciatic nerve induces mechanical and thermal hypersensitivity. Paw mechanical withdrawal thresholds (A) and thermal withdrawal latency (B) were assessed with electronic Von Frey and plantar test analgesia meter, respectively, on ipsilateral hind paws of CCI and sham-operated rats. n = 6 in both groups. All data were represented as mean ± SD. Statistical analyses consisted of repeated measures two-way ANOVA tests followed by Sidak’s multiple comparisons tests. ****P < 0.0001 between Sham and CCI groups.

CCI of sciatic nerve induces mechanical and thermal hypersensitivity. Paw mechanical withdrawal thresholds (A) and thermal withdrawal latency (B) were assessed with electronic Von Frey and plantar test analgesia meter, respectively, on ipsilateral hind paws of CCI and sham-operated rats. n = 6 in both groups. All data were represented as mean ± SD. Statistical analyses consisted of repeated measures two-way ANOVA tests followed by Sidak’s multiple comparisons tests. ****P < 0.0001 between Sham and CCI groups.

MicroRNA Profiles

The miRCURY™ LNA Array (v7.0, Exiqon) detected 705 rat microRNAs (). Hierarchical clustering and scatter plot visualization showed the microRNA expression levels were different. Overall, 13 of them were calculated as differential microRNAs (fold change ≥ 2.0) between the CCI and Sham groups. Six of them were significantly upregulated, and the other seven were downregulated in CCI group. microRNA-1b overexpressed 18.7 times (intensity 2282 vs 113) after CCI insult. The 13 differential microRNAs are listed in Table 1.
Table 1

Differentially Expressed microRNAs Between Sham-Operated And CCI Rats

microRNAFold ChangeIntensity (CCI)Intensity (Sham)
Upregulated in CCI
rno-miR-1b18.72282113
rno-miR-98-5p3.7784195
rno-miR-31a-3p2.6281101
rno-miR-376b-5p2.2529218
rno-miR-1-3p2.25724
rno-miR-214-3p2.13716
Downregulated in CCI
rno-miR-329-5p−3.7226781
rno-miR-675-5p−2.960163
rno-miR-342-5p−2.73484
rno-miR-203a-3p−2.62866
rno-let-7d-5p−2.5121279
rno-miR-542-5p−2.41941
rno-miR-672-5p−2.21632
Differentially Expressed microRNAs Between Sham-Operated And CCI Rats

LncRNA Profiles

By using the Arraystar Rat LncRNA/mRNA chips (v2.0, 4 × 44k, Arraystar), 10,430 rat lncRNAs were detected (). Hierarchical clustering and scatter plot visualization showed the lncRNAs expression levels were different. Overall, 876 of them were calculated as differential lncRNAs (fold change ≥ 2.0) between the CCI and Sham groups. Among them, 339 were significantly upregulated, and the other 537 were downregulated in CCI group (). Sixteen of them differentially expressed more than 10 times and the lncRNA XR_356687 (sequence: GTTCATTATCGGAATTAACCAGACATATCGTTCCACCAACTAAGAACGGCCATGCACCAC) overexpressed 53 times (raw intensity: 19,188 vs 364). The top 20 significantly up- and downregulated lncRNAs are listed, respectively, in Table 2.
Table 2

Differentially Expressed lncRNAs Between Sham-Operated And CCI Rats

lncRNA (Seq Name)Gene SymbolFold ChangeRaw Intensity (CCI)Raw Intensity (Sham)
Top 20 upregulated in CCI
XR_356687LOC10255232552.519,188364
XR_592109LOC10254641022.31075
XR_598798LOC10254911615.2735
XR_347276Fancm13.9675
XR_347276Fancm13.9675
XR_592810LOC10255150313.0635
XR_593301LOC10091224212.7615
XR_347392Lin528.8587
XR_593865LOC1025506328.3405
XR_601438LOC1036926367.8405
XR_595336LOC1036936456.7325
XR_346855LOC1025488445.95710
XR_357290LOC1025535505.6387
XR_590881LOC1036914495.6275
XR_340868LOC1025500645.69518
XR_591045LOC1036915285.5275
XR_592900LOC1036925685.47615
XR_339110LOC1025485505.4275
XR_594520LOC1036932505.3377
XR_340350LOC1025532935.2306
Top 20 downregulated in CCI
ENSRNOT00000034363AABR06081233.1−19.41833600
XR_338868LOC102546527−10.9557
NR_046246Rn28s−10.911,145113,335
NR_046246Rn28s−10.911,145113,335
NR_046246Rn28s−10.911,145113,335
NR_046246Rn28s−10.911,145113,335
XR_342867LOC102555707−10.7555
XR_593141LOC102550062−10.4554
XR_591024LOC102556203−10.3553
XR_338470LOC102553477−9.9660
XR_590615LOC102552001−9.8656
XR_590615LOC102552001−9.8656
XR_601117LOC103695264−9.66606129
XR_352792LOC102551164−8.5544
XR_342721LOC102550786−8.4544
ENSRNOT00000041435LOC367333−8.1542
XR_601956LOC103695347−7.8540
XR_589758LOC103690882−7.4538
ENSRNOT00000075140AABR06019245.1−7.1537
ENSRNOT00000075140AABR06019245.1−7.1557
Differentially Expressed lncRNAs Between Sham-Operated And CCI Rats

mRNA Profiles

The Arraystar Rat LncRNA/mRNA chips detected 19,952 rat mRNAs (). Hierarchical clustering and scatter plot visualization showed the mRNA expression levels were different (Figure 2). Overall, 950 of them were calculated as differential mRNAs (fold change ≥ 2.0) between the CCI and Sham groups. Among them, 405 were significantly upregulated, and 545 were downregulated in the CCI group (). Ten mRNAs changed the expression more than 10 times, and the Hspa1b (encodes heat shock protein 70) overexpressed 24 times in CCI dorsal spinal cord. The top 20 differentially upregulated and downregulated mRNAs are listed, respectively, in Table 3.
Figure 2

mRNA expression between the CCI and sham-operated rats. (A) Hierarchical clustering shows a differential mRNA expression profiles between two groups. The upregulated mRNAs in the CCI group are shown in red, and the downregulated ones are in green. (B) Box plots show the distribution of mRNAs for the two groups. The distributions (the means, the 25th and 75th percentiles) were nearly the same in the CCI and Sham groups after normalization, indicating that the overall expression of mRNA was uniform between the two groups. (C) Scatter plots assess the mRNA expression differences between CCI and Sham groups. The mRNAs above the top green line (indicated with red dot) and below the bottom green line (indicated with green dot) are differential mRNAs (fold change ≥ 2.0 or ≤ −2.0, respectively), while mRNAs with no expression difference are represented with black dots between the two border lines.

Table 3

Differentially Expressed mRNAs Between Sham-Operated And CCI Rats

mRNA (Seq Name)Gene SymbolFold ChangeRaw Intensity (CCI)Raw Intensity (Sham)
Top 20 upregulated in CCI
NM_212504Hspa1b23.94098172
NM_001024740Ccdc11616.41419
NM_001025028Fam35a15.5745
NM_001017496Cxcl1312.836630
ENSRNOT00000008897Ptprd11.637835
NM_001113390Ptprr11.0535
NM_080694Cacng69.613415
NM_001108873Tnfrsf10b9.610511
NM_012912Atf38.91452168
ENSRNOT00000044252Ascl48.6415
NM_001000884Olr11178.5415
ENSRNOT00000026719Col6a38.3729
ENSRNOT00000018645Zc3hav1l8.216221
NM_053551Pdk47.719027
NM_001031637Abca177.5426
NM_001145755Nlrp1a6.79315
ENSRNOT00000010289Apold16.72507381
ENSRNOT00000049430Rbbp66.436562
NM_019216Gdf156.3315
NM_001145072Iqcf56.25910
Top 20 downregulated in CCI
NM_001108582Dapl1−22.011240
ENSRNOT00000032726Cylc2−15.2692
NM_133292Sval1−13.8572
ENSRNOT00000065875AABR06030627.1−13.112163
NM_001108480Bcl2l12−9.7550
NM_001305124Tmem220−9.41471431
NM_001008931Vom1r48−9.012108
ENSRNOT00000046533LOC287992−8.3543
NM_001000659Olr587−7.8540
ENSRNOT00000038519Grhl1−7.616126
NM_001108922Stk32c−7.44243119
ENSRNOT00000060162AABR06088936.1−7.3538
NM_013030Slc34a1−7.1537
NM_001137670Sept14−7.1645
NM_019622Espn−7.12661939
NM_001277165Ldb3−7.0536
NM_001012140Rab34−6.7750
NM_001000809Olr1245−6.7534
NM_001244797Cidec−6.5960
NM_001108926Cabp4−6.5749
mRNA expression between the CCI and sham-operated rats. (A) Hierarchical clustering shows a differential mRNA expression profiles between two groups. The upregulated mRNAs in the CCI group are shown in red, and the downregulated ones are in green. (B) Box plots show the distribution of mRNAs for the two groups. The distributions (the means, the 25th and 75th percentiles) were nearly the same in the CCI and Sham groups after normalization, indicating that the overall expression of mRNA was uniform between the two groups. (C) Scatter plots assess the mRNA expression differences between CCI and Sham groups. The mRNAs above the top green line (indicated with red dot) and below the bottom green line (indicated with green dot) are differential mRNAs (fold change ≥ 2.0 or ≤ −2.0, respectively), while mRNAs with no expression difference are represented with black dots between the two border lines. Differentially Expressed mRNAs Between Sham-Operated And CCI Rats

Bioinformatics Analyses Of Differential mRNA

Gene Ontology enrichment analysis of differential mRNAs in CCI rats was conducted and the top 10 significantly enriched (P < 0.05) GO terms for the upregulated and downregulated mRNAs are listed in Figure 3. The upregulated (Figure 3A–C) and downregulated mRNAs (Figure 3D–F) in CCI rats enriched in biological processes, cellular component, and molecular function terms, such as signaling (GO: 0023052, with 182 genes), cell communication (GO: 0007154, with 182 genes), G-protein-coupled activity (GO: 0048856, with 88 genes), cytokine production (GO: 0001816, with 26 genes), etc.
Figure 3

Gene ontology enrichment analysis. Enriched gene ontology (GO) terms correspond to the 405 differentially upregulated (A-C) mRNAs and 545 downregulated (D-F) mRNAs in CCI group. (A, D) Top 10 significantly (Sig) enriched biological processes (BP) terms for the upregulated and downregulated differentially expressed (DE) mRNAs in CCI group, respectively. (B, E) Top 10 enriched cellular component (CC) terms for the upregulated and downregulated DE mRNAs in CCI group, respectively. (C, F) Top 10 enriched molecular function (MF) terms for the upregulated and downregulated DE mRNAs in CCI group, respectively.

Gene ontology enrichment analysis. Enriched gene ontology (GO) terms correspond to the 405 differentially upregulated (A-C) mRNAs and 545 downregulated (D-F) mRNAs in CCI group. (A, D) Top 10 significantly (Sig) enriched biological processes (BP) terms for the upregulated and downregulated differentially expressed (DE) mRNAs in CCI group, respectively. (B, E) Top 10 enriched cellular component (CC) terms for the upregulated and downregulated DE mRNAs in CCI group, respectively. (C, F) Top 10 enriched molecular function (MF) terms for the upregulated and downregulated DE mRNAs in CCI group, respectively. KEGG pathway analysis showed that the differential mRNAs significantly enriched (P < 0.05) in 32 pathways, with the up- and downregulated mRNAs in CCI group enriched to 16 pathways, respectively (Figure 4). The upregulated mRNAs enriched to TNF (7 genes), FoxO (7 genes), apoptosis (5 genes), Cytokine-cytokine receptor interaction (4 genes), Toll-like receptor signaling pathway (5 genes), etc. (Figure 4A), and the downregulated mRNAs enriched to cocaine addiction (4 genes), calcium signaling pathway (9 genes), cell adhesion molecules (CAMs, 8 genes), and glutamatergic synapse (6 genes) pathway (Figure 4B).
Figure 4

KEGG pathways significantly enriched by differentially expressed mRNAs. (A) Pathways significantly enriched (P < 0.05) by the upregulated mRNAs in CCI group. (B) KEGG pathways significantly enriched (P < 0.05) by the downregulated mRNAs in CCI group.

KEGG pathways significantly enriched by differentially expressed mRNAs. (A) Pathways significantly enriched (P < 0.05) by the upregulated mRNAs in CCI group. (B) KEGG pathways significantly enriched (P < 0.05) by the downregulated mRNAs in CCI group.

Discussion

Spinal dorsal horn is an important location for pain central sensatization, pathological pain starting and maintaining, and therefore, neuropathic pain treatment.8 In this study, the expression profiles in neuropathic pain rats’ dorsal spinal cord were detected with different microarrays. Comprehensive expression changes of transcripts including microRNA, lncRNA, and mRNA were found between normal and CCI rats. These results indicate that dorsal spinal cord and these differentially expressed molecules can be targets for neuropathic pain. In this study, 13 microRNAs were found differentially expressed in neuropathic pain rats, and miR-1b overexpressed 18.7 times in CCI rats, indicating that these differential microRNAs may be involved in the chronic pain process of CCI rats. To date, the expression level of miR-1b in dorsal spinal cord after neuropathic pain is not reported. One study detected the expression of miR-1b in the injured sciatic nerve; interestingly, its expression decreased in the peripheral nerve injury rats. The functional study indicated that miR-1b can negatively regulate nerve regeneration by influencing proliferation, migration, and apoptosis of Schwann cells.38 MicroRNAs are mainly involved in the regulation of biological processes by inhibiting the function of their target genes. To evaluate the function of these microRNAs, prediction of target genes and gain- and/or loss-of-function experiments are needed for subsequent studies. There are 876 differential lncRNAs between neuropathic pain and normal rats in this study, and 16 of them are differentially expressed more than 10 times. Of note, the lncRNA XR_356687 overexpressed as high as 53 times in CCI rats’ dorsal horn, although its expression level in normal rats is already high (with raw intensity: 19,188 vs 364). This suggests that lncRNAs in the dorsal spinal cord actively participated in the neuropathic pain development. Of course, the biological regulation mechanism of lncRNA is complex, and further studies are needed to confirm these differential lncRNAs’ effects and the specific mechanisms in neuropathic pain environment. In addition, 405 upregulated and 545 downregulated mRNAs were detected in CCI group. Ten of them show an expression level change of more than 10 times. The Hspa1b mRNA, which encodes heat shock protein 70 (HSP70), overexpressed 24 times in the spinal cord of CCI rats. HSP70 is an abundant and quickly inducible protein, which is constitutively expressed at normal growth temperatures and functions as a molecular chaperone.39 It is reported that HSP70-TLR4 axis attenuated neuroinflammation and ameliorated postoperative pain.40 GO analyses showed they enriched into GO terms such as signaling, cell communication, G-protein-coupled activity, and cytokine production, which are closely related to physical function and in the spinal dorsal horn, the imbalance of their function takes part in neuropathic pain development.10,41–43 KEGG pathway analyses show that these differential mRNAs enriched into 32 KEGG pathways, including TNF, cytokine–cytokine receptor interaction, calcium signaling, and FoxO pathway. The TNF,44,45 cytokine,8,43,46 and calcium-related pathway47,48 contribute to neuropathic pain development in the dorsal spinal cord. Although FoxO has not been confirmed to take part in the neuropathic pain, bioinformatics predicted that FoxO pathway in the dorsal spinal cord37 or dorsal root ganglion49 was related to neuropathic pain. We previously found that circular RNA (circRNA) expression levels in the dorsal spinal cord of CCI rats were significantly changed.37 A total of 469 circRNAs showed differential expression between CCI and sham-operated rats.37 These data again suggest that neuropathic pain induced comprehensive changes of transcription profile in the dorsal spinal cord. A growing body of evidence suggests that changes in the transcriptome of the dorsal spinal cord are dynamic in neuropathic pain.16,21,50 However, even in animal models of the same kind of neuropathic pain, such as the peripheral nerve injury induced pain, detected changes in expression profiles and biological pathways are not identical, suggesting that outcomes in dorsal spinal cord molecules may be related to pain duration, pain intensity, and different kinds of species. Besides, recent pieces of evidence revealed that there are reciprocal regulations among the non-coding RNAs and mRNAs. For instance, microRNAs bind to the 3ʹ-untranslated region of their target mRNAs and lead to degradation and translational repression, while lncRNA and circRNAs can function as microRNA sponges51,52 and regulate parent gene expression to affect disease outcomes.52,53 In addition, to further distinguish the cell source of differential gene from the dorsal spinal cord, single-cell separation technique is a feasible method. For example, microglia were collected and subjected to microarray analysis at the spinal dorsal horn; results suggest that differential gene Gria1 is specific for microglia, 56 genes and microRNA-29c may play an important role in the pathogenesis and maintenance of neuropathic pain.21 For the tissue collection, not only the spinal dorsal horn but the whole CCI-ipsilateral dorsal spinal cord was collected, six dorsal spinal cord tissues were pooled as one detection sample; however, repeated microarray detections (e.g., three repeats) and a set P value (e.g., <0.05) are better to detect the differential transcripts. Data in this study are all from male rats; it should be realized that sex difference may influence the detected differential genes.54,55 Expression validation and function-oriented experiments of specific differential microRNA, lncRNA, or mRNA are warranted to clarify their roles in neuropathic pain regulation.

Conclusion

Neuropathic pain induced comprehensive transcriptome changes in the dorsal spinal cord. The differentially expressed transcripts such as microRNA, lncRNA, and mRNA in spinal dorsal horn could be potential targets in defeating neuropathic pain. Strategies targeting these differentially expressed molecules such as microRNA-1b, the lncRNA XR_356687, and HSP70 in spinal dorsal horn may be helpful to relieve neuropathic pain.
  54 in total

1.  miR-1b overexpression suppressed proliferation and migration of RSC96 and increased cell apoptosis.

Authors:  Yu-Pu Liu; Peng Xu; Chun-Xia Guo; Zhi-Rong Luo; Jing Zhu; Fang-Fang Mou; Hao Cai; Chang Wang; Xiao-Chun Ye; Shui-Jin Shao; Hai-Dong Guo
Journal:  Neurosci Lett       Date:  2018-09-24       Impact factor: 3.046

Review 2.  Pain regulation by non-neuronal cells and inflammation.

Authors:  Ru-Rong Ji; Alexander Chamessian; Yu-Qiu Zhang
Journal:  Science       Date:  2016-11-04       Impact factor: 47.728

3.  Different immune cells mediate mechanical pain hypersensitivity in male and female mice.

Authors:  Robert E Sorge; Josiane C S Mapplebeck; Sarah Rosen; Simon Beggs; Sarah Taves; Jessica K Alexander; Loren J Martin; Jean-Sebastien Austin; Susana G Sotocinal; Di Chen; Mu Yang; Xiang Qun Shi; Hao Huang; Nicolas J Pillon; Philip J Bilan; YuShan Tu; Amira Klip; Ru-Rong Ji; Ji Zhang; Michael W Salter; Jeffrey S Mogil
Journal:  Nat Neurosci       Date:  2015-06-29       Impact factor: 24.884

Review 4.  Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.

Authors:  Ralf Baron; Andreas Binder; Gunnar Wasner
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

Review 5.  Circuitry and plasticity of the dorsal horn--toward a better understanding of neuropathic pain.

Authors:  S J West; K Bannister; A H Dickenson; D L Bennett
Journal:  Neuroscience       Date:  2015-05-16       Impact factor: 3.590

Review 6.  MicroRNA and chronic pain: From mechanisms to therapeutic potential.

Authors:  María José López-González; Marc Landry; Alexandre Favereaux
Journal:  Pharmacol Ther       Date:  2017-06-01       Impact factor: 12.310

7.  NEAT1 contributes to neuropathic pain development through targeting miR-381/HMGB1 axis in CCI rat models.

Authors:  Lie-Xin Xia; Chengming Ke; Jing-Min Lu
Journal:  J Cell Physiol       Date:  2018-04-10       Impact factor: 6.384

8.  Identification of key genes and pathways associated with neuropathic pain in uninjured dorsal root ganglion by using bioinformatic analysis.

Authors:  Chao-Jin Chen; De-Zhao Liu; Wei-Feng Yao; Yu Gu; Fei Huang; Zi-Qing Hei; Xiang Li
Journal:  J Pain Res       Date:  2017-11-14       Impact factor: 3.133

9.  8-O-Acetyl Shanzhiside Methylester From Lamiophlomis Rotata Reduces Neuropathic Pain by Inhibiting the ERK/TNF-α Pathway in Spinal Astrocytes.

Authors:  Wei Zhang; Yang Bai; Yu Qiao; Jian Wang; Meng-Ying Li; Jing-Wen Wang; Na Jia; Tao Chen; Yun-Qing Li; Ai-Dong Wen
Journal:  Front Cell Neurosci       Date:  2018-03-08       Impact factor: 5.505

10.  Peripheral nerve injury increases contribution of L-type calcium channels to synaptic transmission in spinal lamina II: Role of α2δ-1 subunits.

Authors:  Sascha Ra Alles; Esperanza Garcia; Sridhar Balasubramanyan; Karen Jones; John R Tyson; Twinkle Joy; Terrance P Snutch; Peter A Smith
Journal:  Mol Pain       Date:  2018 Jan-Dec       Impact factor: 3.395

View more
  8 in total

1.  Alterations in mouse spinal cord and sciatic nerve microRNAs after the chronic constriction injury (CCI) model of neuropathic pain.

Authors:  Jenny L Wilkerson; Jinmai Jiang; Jasmine S Felix; Julie K Bray; Lais da Silva; Raad Z Gharaibeh; Lance R McMahon; Thomas D Schmittgen
Journal:  Neurosci Lett       Date:  2020-05-05       Impact factor: 3.046

2.  Microarray analysis of potential biomarkers of brachial plexus avulsion caused neuropathic pain in male rat.

Authors:  Le Wang; Jie Lao
Journal:  BMC Neurosci       Date:  2022-05-26       Impact factor: 3.264

3.  Analysis of Epigenetic Age Predictors in Pain-Related Conditions.

Authors:  Katarzyna Malgorzata Kwiatkowska; Maria Giulia Bacalini; Claudia Sala; Helena Kaziyama; Daniel Ciampi de Andrade; Rossana Terlizzi; Giulia Giannini; Sabina Cevoli; Giulia Pierangeli; Pietro Cortelli; Paolo Garagnani; Chiara Pirazzini
Journal:  Front Public Health       Date:  2020-06-09

4.  Systemic gene expression profiles according to pain types in individuals with chronic spinal cord injury.

Authors:  Debra Morrison; Anthony A Arcese; Janay Parrish; Katie Gibbs; Andrew Beaufort; Paige Herman; Adam B Stein; Ona Bloom
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

Review 5.  Differential Expression of Long Non-Coding RNAs and Their Role in Rodent Neuropathic Pain Models.

Authors:  Songchao Xu; He Dong; Yang Zhao; Wei Feng
Journal:  J Pain Res       Date:  2021-12-30       Impact factor: 3.133

Review 6.  New Vistas in microRNA Regulatory Interactome in Neuropathic Pain.

Authors:  Yash Gada; Amitkumar Pandey; Nikita Jadhav; Saiprasad Ajgaonkar; Dilip Mehta; Sujit Nair
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

7.  Protein Tyrosine Phosphatase Receptor Type D Regulates Neuropathic Pain After Nerve Injury via the STING-IFN-I Pathway.

Authors:  Chengkuan Sun; Guangzhi Wu; Zhan Zhang; Rangjuan Cao; Shusen Cui
Journal:  Front Mol Neurosci       Date:  2022-04-14       Impact factor: 5.639

Review 8.  The etiological roles of miRNAs, lncRNAs, and circRNAs in neuropathic pain: A narrative review.

Authors:  Ming Jiang; Yelong Wang; Jing Wang; Shanwu Feng; Xian Wang
Journal:  J Clin Lab Anal       Date:  2022-07-09       Impact factor: 3.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.